Mixed Salts Amphetamine
Attention Deficit-Hyperactivity Disorder
University of CincinnatiUNKNOWNPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Attention Deficit-Hyperactivity Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Methylphenidate Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Phase 4 | BBB |
Olanzapine Washington University School of Medicine | Phase 4 | BB |
Lis-Dexamphetamine Duke University | Phase 4 | B |
Sertraline Holland Bloorview Kids Rehabilitation Hospital | Phase 2 | CCC |
Dextromethorphan Prof. Dr. Frank Behrens | Phase 2 | CCC |
View all 9 →
Same molecule, other indications
Mixed Salts Amphetamine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →